A Phase 3, Open-label, Multicenter Randomized Trial to Evaluate Humoral Immunogenicity of Various Schedules of Intramuscular Full-Dose and Intradermal Fractional Dose of Inactivated Polio Vaccine in Latin American Infants
Latest Information Update: 21 Apr 2023
At a glance
- Drugs Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary) ; Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- 28 Apr 2021 New trial record
- 01 Apr 2021 Results published in The Lancet Infectious Diseases